Janus Henderson Group PLC Mannkind Corp Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Mannkind Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 127,763 shares of MNKD stock, worth $709,084. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127,763

Previous 127,763 -0.0%

Holding current value

$709,084

Previous $642,000 25.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$5.93 - $7.44 $134,611 - $168,888	22,700 Added 21.61%	127,763 $821,000
Q2 2024 Aug 14, 2024	SELL	$4.05 - $5.43 $5,463 - $7,325	-1,349 Reduced 1.27%	105,063 $548,000
Q1 2024 May 15, 2024	BUY	$3.25 - $5.27 $35 - $57	11 Added 0.01%	106,412 $482,000
Q4 2023 Feb 14, 2024	SELL	$3.34 - $4.29 $674 - $866	-202 Reduced 0.19%	106,401 $387,000
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $70 - $98	18 Added 0.02%	106,603 $440,000
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $282 - $364	-76 Reduced 0.07%	106,585 $433,000
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $231,438 - $329,872	58,592 Added 121.89%	106,661 $437,000
Q4 2022 Feb 14, 2023	SELL	$3.02 - $5.37 $15 - $26	-5 Reduced 0.01%	48,069 $253,000
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $50 - $73	17 Added 0.04%	48,074 $149,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $16 - $28	-6 Reduced 0.01%	48,057 $183,000
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $47 - $80	18 Added 0.04%	48,063 $178,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $97,856 - $129,749	24,162 Added 101.17%	48,045 $210,000
Q3 2021 Nov 16, 2021	BUY	$3.89 - $5.48 $92,904 - $130,878	23,883 New	23,883 $104,000
Q1 2020 May 14, 2020	SELL	$0.84 - $1.76 $23,483 - $49,202	-27,956 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$1.14 - $1.49 $599 - $783	526 Added 1.92%	27,956 $36,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $318 - $440	306 Added 1.13%	27,430 $34,000
Q2 2019 Jul 31, 2019	SELL	$1.09 - $1.88 $6,378 - $11,001	-5,852 Reduced 17.75%	27,124 $31,000
Q1 2019 Apr 30, 2019	BUY	$1.14 - $2.25 $17,962 - $35,453	15,757 Added 91.51%	32,976 $65,000
Q4 2018 Feb 06, 2019	SELL	$1.02 - $2.05 $5,155 - $10,360	-5,054 Reduced 22.69%	17,219 $18,000
Q3 2018 Nov 09, 2018	BUY	$1.01 - $2.19 $5,374 - $11,652	5,321 Added 31.39%	22,273 $41,000
Q2 2018 Aug 10, 2018	BUY	$1.59 - $2.38 $26,953 - $40,345	16,952 New	16,952 $32,000

Others Institutions Holding MNKD

# of Institutions

251

Shares Held

161M

Call Options Held

1.24M

Put Options Held

183K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.43B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Mannkind Corp Transaction History